Related Experiment Video
Updated: Jun 23, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Medullary thyroid carcinoma and tuberous sclerosis
Palma Dicorato1, Anna Calvanese, Amelia Maiuolo
1Department of Experimental Medicine, Sapienza University of Rome, V.le Regina Elena, 324, Rome, 00161, Italy.
Endocrine Pathology
|May 9, 2009
Summary
Tuberous sclerosis (TS) is a rare neurocutaneous syndrome. This report details a unique case of TS associated with medullary thyroid carcinoma (MTC), suggesting thyroid screening for TS patients.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Medullary thyroid carcinoma (MTC) is a rare endocrine malignancy, comprising 5-10% of all thyroid cancers.
- Tuberous sclerosis (TS) is an autosomal dominant neurocutaneous syndrome associated with increased neoplasia risk in various organs.
- Existing literature has documented associations between TS and several endocrine neoplasias, but not sporadic MTC.
Observation:
- This report presents a unique, previously undocumented case of MTC occurring in a patient with TS.
- The patient's presentation highlights a novel association between TS and sporadic MTC.
Findings:
- The co-occurrence of TS and sporadic MTC expands the known spectrum of neoplasias associated with TS.
- This case underscores the potential for MTC development in individuals with TS.
Implications:
- The findings suggest that TS may confer an increased risk for developing MTC.
- Routine thyroid screening is recommended for patients diagnosed with tuberous sclerosis to facilitate early detection of MTC.
Related Concept Videos
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...